Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
02/2011
02/23/2011EP1812388B1 Sulfonamide peri-substituted bicyclics for occlusive artery disease
02/23/2011CN1942466B Caspase inhibitors and uses thereof
02/23/2011CN101981006A Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
02/23/2011CN101979379A Method for preparing 3-acetonyl-3-hydroxy oxindole (AHO)
02/23/2011CN101039907B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
02/22/2011US7893279 Cyclohexanecarboxylic acid compound
02/22/2011US7893102 Fluoroalkoxy-substituted 1,3-dihydro-isoindolyl compounds and their pharmaceutical uses
02/22/2011US7893101 Reducing tumor necrosis factor, phosphodiesterase inhibitor; anticancer agents; leukemia; antidepressants; antiinflammatory agents; respiratory system disorders
02/22/2011US7893100 carvedilol phosphate salts, which include novel crystalline forms of carvedilol dihydrogen phosphate (i.e., dihydrogen phosphate salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy) ethyl]amino]-2-propanol) and/or carvedilol hydrogen phosphate, etc.), and/or solvates , compositions containing compounds
02/22/2011US7893098 Pyrrole and pyrazole DAAO inhibitors
02/22/2011US7893084 Viral polymerase inhibitors
02/22/2011US7893071 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic
02/22/2011US7892297 Cyanin-type compounds having an alkynyl linker arm
02/22/2011CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/22/2011CA2470575C Spiroazacyclic compounds as monoamine receptor modulators
02/22/2011CA2403139C Novel 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and medicaments containing these compounds
02/17/2011WO2011019634A2 Aryl substituted sulfonamide compounds and their use as anticancer agents
02/17/2011WO2011019173A2 Compound containing 5-membered heterocycles, organic light-emitting device using same, and terminal comprising the latter
02/17/2011WO2011019156A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/17/2011WO2011019060A1 Hedgehog signal inhibitor
02/17/2011WO2011018886A1 Organic compound and organic light-emitting device using the same
02/17/2011WO2011018384A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation
02/17/2011WO2011018144A2 Phenanthro[1,10,9,8-c,d,e,f,g]carbazole polymers and their use as organic semiconductors
02/17/2011US20110039908 Inhibiting Amyloid-Beta Peptide/Rage Interaction At The Blood-Brain Barrier
02/17/2011US20110039880 Aryl substituted sulfonamide compounds and their use as anticancer agents
02/17/2011US20110039855 Tetrahydrocyclopenta[b]indole Androgen Receptor Modulators
02/17/2011US20110039827 Substituted hydroxamic acids and uses thereof
02/17/2011US20110039819 Substituted phenoxybenzamides
02/17/2011US20110039808 Multitarget Compounds Active at a PPAR and Cannabinoid Receptor
02/17/2011US20110039802 Npy y5 antagonist
02/17/2011US20110038803 specifically and efficiently traps nitrogen monoxide, zinc ion etc. to emit fluorescence; used to measure nitrogen monoxide or metal ions in a deep tissue of a living body
02/17/2011US20110037060 Organic light emitting device
02/17/2011US20110037057 Deuterated compounds for electronic applications
02/17/2011CA2770896A1 Cathepsin c inhibitors
02/17/2011CA2770801A1 Pesticidal carboxamides
02/17/2011CA2770724A1 Compounds and methods of use thereof
02/17/2011CA2769761A1 Bi - or tricyclic sterically hindered alkoxyamines and process for their preparation
02/16/2011EP2284149A1 Selective androgen receptor modulators and methods of use thereof
02/16/2011EP2282994A1 3-aminocarbazole compound, pharmaceutical composition containing it and preparation method therefor
02/16/2011EP2282993A1 Process for preparing 3-indolyl fatty acid amides with saturated, unsaturated or hydroxy fatty acids
02/16/2011CN1972926B Indole derivatives as histamine receptor antagonists
02/16/2011CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands
02/16/2011CN1696107B Low temperature method for preparing derivative of tri-arylamine group and application
02/16/2011CN101977898A Spiroindolinone derivatives
02/16/2011CN101977897A Methods of preparing polymorphic form a of bazedoxifene acetate
02/16/2011CN101973926A Method for preparing R-mitiglinide calcium
02/16/2011CN101973925A 2-indolone compound with anti-inflammatory activity, preparation method and medicinal application thereof
02/16/2011CN101973924A Preparation method of 2-methyl-3-ethyl-4ketone-4, 5, 6, 7-tetralin indol and analogue thereof
02/16/2011CN101973829A Trifluoromethylation of trifluoromethyl aryl sulfonium salt to heterocyclic compound under metal trigger
02/16/2011CN101184729B Inhibitors of cytosolic phospholipase a2
02/16/2011CN101100416B Small molecule inhibitor for preventing Alzheimer's disease Abeta polypeptide from fiberizing and its preparation method, pharmaceutical composition and application
02/16/2011CN101048465B Polymeric luminescent material composition and polymeric light-emitting device
02/15/2011US7888398 chlorinated subphthalocyanine coordinated with boron trichloride; ink for color filter; blue-colored pixels of excellent lightfastness, solvent resistance and heat resistance; brightnesss; saturation; kneading with alcohol solvent and inorganic salt (NaCl): narrow particle size distribution
02/15/2011US7888384 Heterocyclic derivatives for modulation of calcium channels
02/15/2011US7888383 Organic compounds
02/15/2011US7888363 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
02/15/2011US7888336 Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity
02/15/2011US7888285 2,4,6-phenyl substituted cyclic ketoenols
02/15/2011CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
02/15/2011CA2478156C Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
02/15/2011CA2455453C Taxol enhancer compounds
02/10/2011WO2011016648A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/10/2011US20110034705 Process For the Synthesis of 3- Amino-3-Cyclobuthylmethyl-2-Hydroxypropionamide or Salts Thereof
02/10/2011US20110034704 Laboratory scale continuous flow hydrogenation process
02/10/2011US20110034461 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments
02/10/2011US20110034440 Homocysteine synthase inhibitor
02/10/2011US20110033544 Intranasal pharmaceutical compositions with improved pharmacokinetcs
02/10/2011US20110033417 2,3-substituted indole derivatives for treating viral infections
02/10/2011US20110033393 Hydrazone Compounds and Their Use
02/10/2011US20110031484 Condensed-cyclic compound and organic light emitting diode having organic layer including the same
02/10/2011US20110031483 Organic light emitting device
02/09/2011EP2281815A1 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound
02/09/2011EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy
02/09/2011EP2280943A1 New substituted spiroýcycloalkyl-1,3'-indol¨-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors.
02/09/2011EP2280942A1 Indolesulfonyl protecting groups for protection of guanidino and amino groups
02/09/2011EP2280941A1 (hetero-)aryl cyclohexane derivatives
02/09/2011EP1654224B1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
02/09/2011EP1644321B1 New benzamides as ppaty modulators
02/09/2011EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
02/09/2011CN1678580B Iminoalkanpercarboxylic acids
02/09/2011CN101970407A Process for the manufacture of a 6-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene derivative
02/09/2011CN101970406A Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
02/09/2011CN101970405A Indoles and their therapeutic use
02/09/2011CN101970401A Leukotriene b4 inhibitors
02/09/2011CN101624366B Industrialized cleaning production process of captan
02/09/2011CN101492407B Method for organic catalysis synthesis of beta-indole aldehyde
02/09/2011CN101293864B Compound having affinity with brain A beta plaque, preparation method and application thereof
02/08/2011US7884220 Process for purifying PPPBP
02/08/2011US7884219 Receptor antagonist of advanced glycosylation endproducts ; antiinflammatory agents; Alzheimer's disease; anticancer, antitumor agent; autoimmune disease; antiarthritic agents; multiple sclerosis; diabetic nephropathy; cardiovascular disorders; osteoporosis
02/08/2011US7884218 Benzoindole-based compound and dye-sensitized solar cell using the same
02/08/2011US7884204 Phenylalanine derivatives
02/08/2011US7884092 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
02/08/2011US7883787 Organometallic complexes as phosphorescent emitters in organic LEDs
02/08/2011US7883786 Biphenyl derivative and organic light-emitting element using same
02/08/2011US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
02/08/2011CA2479906C Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
02/08/2011CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them
02/08/2011CA2459374C Photoactivable nitrogen bases
02/08/2011CA2446924C 2-iminopyrrolidine derivatives
02/08/2011CA2442319C Carboxylic acid derivative and salt thereof
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 458